๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous Melanocytic Neoplasm

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma NCT03860883NA192 sites๐Ÿ“ Mobile๐Ÿ“ Gilbert๐Ÿ“ Phoenix Melanoma and Skin Cancer Trials Limited ยท Tests: Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade NCT07130032Phase 21 site๐Ÿ“ Saint Petersburg EuroCityClinic LLC ยท Tests: reICB regimen (NSCLC), reICB regimen (melanoma) Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) NCT05549297Phase 382 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Orlando Immunocore Ltd ยท Tests: Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site๐Ÿ“ Columbus Carlo Contreras ยท Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317Phase 22 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging The MELAcare Study: A New Method for Surveillance of Melanoma Patients NCT05253872NA1 site๐Ÿ“ Copenhagen Herlev and Gentofte Hospital ยท Tests: The MelaCare intervention A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Rancho Santa Margarita๐Ÿ“ Weston Krystal Biotech, Inc. ยท Tests: KB707, Opdualag, KEYTRUDA ยฎ( Pembrolizumab) A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ New Haven GV20 Therapeutics ยท Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDAยฎ], GV20-0251 and Pembrolizumab [KEYTRUDAยฎ] A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma NCT06624644Phase 2, Phase 39 sites๐Ÿ“ Newport Beach๐Ÿ“ San Francisco๐Ÿ“ Stanford Linnaeus Therapeutics, Inc. ยท Tests: LNS8801, Pembrolizumab, Chemotherapy (dacarbazine or temozolomide), Immunotherapy (Pembrolizumab), Immunotherapy (nivolโ€ฆ A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites๐Ÿ“ Phoenix๐Ÿ“ San Francisco๐Ÿ“ Hartford BioNTech SE ยท Tests: BNT326, Pumitamig, Itraconazole, Paroxetine Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma NCT07631325Phase 1, Phase 21 site๐Ÿ“ Pittsburgh John Kirkwood ยท Tests: Axelopran, Nivolumab Neoadjuvant Combination Immunotherapy for Stage III Melanoma NCT03842943Phase 21 site๐Ÿ“ Louisville University of Louisville ยท Tests: Pembrolizumab, Talimogene Laherparepvec A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites๐Ÿ“ Munich๐Ÿ“ Wรผrzburg๐Ÿ“ Mรผnster Kupando GmbH ยท Tests: KUP-101A Pancreas Registry and High Risk Registry NCT02775461n/a2 sites๐Ÿ“ New York๐Ÿ“ New York Icahn School of Medicine at Mount Sinai Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria NCT07251335n/a1 site๐Ÿ“ Modena University of Modena and Reggio Emilia MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Durham Memgen, Inc. ยท Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma NCT06194929Phase 1, Phase 22 sites๐Ÿ“ Iowa City๐Ÿ“ Salt Lake City University of Utah ยท Tests: Defactinib, Avutometinib, Encorafenib A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information NCT07621614Phase 213 sites๐Ÿ“ Oakland๐Ÿ“ Wilmington๐Ÿ“ Jacksonville Children's Oncology Group ยท Tests: Biospecimen Collection, Chest Radiography, Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain NCT05588453Phase 1, Phase 21 site๐Ÿ“ Columbus Kari Kendra ยท Tests: Natural Killer Cell Therapy, Temozolomide ACTengineยฎ IMA203 Combined With mRNA-4203 NCT06946225Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ New York Immatics US, Inc. ยท Tests: IMA203, mRNA-4203 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Neurocutaneous Melanocytosis Registry NCT04548817n/a2 sites๐Ÿ“ Boston๐Ÿ“ New York Memorial Sloan Kettering Cancer Center Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker NCT07266142n/a1 site๐Ÿ“ Leuven Universitaire Ziekenhuizen KU Leuven ยท Tests: Collection of Human Body Material and Clinical Data Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma NCT07404605NA1 site๐Ÿ“ Ljubljana Institute of Oncology Ljubljana ยท Tests: Electrochemotherapy Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Stanford Anusha Kalbasi ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma NCT06488482Phase 326 sites๐Ÿ“ Helsinki๐Ÿ“ Kuopio๐Ÿ“ Tampere Uppsala University ยท Tests: nivolumab or pembrolizumab Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy